| Home | Search | Site Map |
topheaderright Antyra The Next Generation in Biologicals

Board of Directors

Ronald Pepin, Ph.D.
Robert Taber, Ph.D.
Yuichi Iwaki, M.D., Ph.D.
Paul Larue
Robert Taber, Ph.D.
Lee Eppstein, Ph.D.
John Prendergast, Ph.D.
Neil Goldstein, Ph.D.

Sr. Vice-President Business Development, Medarex
Industry Consultant
CEO, MediciNova
SwansPlace Ltd.
Former Head of Research, DuPont Merck

CTO, New Brunswick Scientific
Executive Chairman & CEO, Antyra
President & CSO, Antyra